Vitality Watch

Dossier pubmed observational 15-dec-2025
Human cohort, case-control, or epidemiological association

Sensorimotor function as an early marker of cognitive decline and alzheimer’s biomarker burden.

Key claim: In cognitively normal older adults, slower gait speed and lower grip strength predict worse cognitive performance and faster decline, and slower gait speed associates with higher CSF tau/Aβ burden and plasma NfL.

Abstract

Early identification of markers of cognitive decline in cognitively normal older adults is essential for dementia prevention strategies. Sensorimotor measures, such as gait speed, grip strength, and reaction time, may provide sensitive indicators of current and future impairment. This study examined associations between baseline sensorimotor function and cognitive decline in cognitively normal older adults. In this prospective cohort, 246 cognitively normal older adults from the DRIVES Project completed baseline assessments of grip strength, gait speed, simple reaction time, and the Preclinical Alzheimer Cognitive Composite (PACC). Participants were followed for a mean of 4 years. Linear mixed-effects models adjusted for demographics, APOE ε4 status, and neighborhood deprivation. Cross-sectional analyses evaluated the associations between sensorimotor measures and cerebrospinal fluid (CSF) biomarkers of amyloid, tau, and plasma neurofilament light chain (NfL). Participants (mean age: 74.9 ± 5.17 years; 48.8% female) had a mean baseline PACC score of 1.06 ± 0.50. Cross-sectionally, slower gait speed was associated with higher CSF tau/Aβratio (p = 0.027), CSF tTau/Aβratio (p = 0.009), and plasma NfL (p = 0.024). A slower reaction time was associated with lower baseline PACC scores (p = 0.028). Longitudinally, low grip strength (p = 0.002) and slow gait speed (p < 0.001) were predictive of lower cognitive performance, with slow gait speed also predicting a faster decline (p = 0.015). Sensorimotor function measures are associated with current and future cognitive performance, supporting their role in early identification of older adults at risk for cognitive decline.

Why this matters

This finding tightens the empirical bridge between bedside functional-aging measures (gait, grip) and molecular AD biomarkers (CSF tau/Aβ, plasma NfL) in people who are still cognitively normal. For an area where most sensorimotor-cognition links are inferred from frailty literature, direct biomarker-anchored observational evidence raises the plausibility that these cheap tests index the same preclinical neuropathology that expensive assays detect — without yet proving causality or that intervening on gait speed moves the biomarkers.

Source

Link

Briefing card

Sensorimotor function as an early marker of cognitive decline and alzheimer's biomarker burden.
Stage: observational · pubmed · 15-dec-2025

If you track gait speed or grip strength as a longevity metric, this cohort found both also move with early Alzheimer's biomarker burden in people without cognitive symptoms.

In cognitively normal older adults, slower gait speed and lower grip strength predict worse cognitive performance and faster decline, and slower gait speed associates with higher CSF tau/Aβ burden and plasma NfL.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-025-02055-0

build build 880 · 2bcef25 · 2026-11-18